Adela Dashian, an analyst from Jefferies, maintained the Hold rating on Vimian Group AB. The associated price target remains the same with SEK37.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adela Dashian has given his Hold rating due to a combination of factors reflecting both solid progress and remaining uncertainties. Vimian reported slightly better‑than‑expected Q4 results, with mid‑single‑digit organic revenue growth and a small uplift in margins, confirming that the business is stabilizing after a weaker period and that recent operational measures are starting to bear fruit.
At the same time, profitability is uneven across segments, as higher investment needs in Veterinary Services and Diagnostics are still constraining group margins, and U.S. orthopaedics, while improving, remains in recovery mode. With the share price having de‑rated but the upside to the price target implying only a more balanced risk‑reward profile relative to execution risks and investment requirements, she views the stock as fairly valued for now and therefore maintains a Hold stance.
According to TipRanks, Dashian is a 4-star analyst with an average return of 7.0% and a 46.88% success rate. Dashian covers the Industrials sector, focusing on stocks such as Munters Group AB, Tomra Systems ASA, and AFRY AB Class B.
In another report released on February 4, TipRanks – xAI also reiterated a Hold rating on the stock with a SEK28.00 price target.

